Free Trial

Doximity (NASDAQ:DOCS) Stock Rating Upgraded by KeyCorp

Doximity logo with Medical background

Doximity (NASDAQ:DOCS - Get Free Report) was upgraded by equities research analysts at KeyCorp from a "sector weight" rating to an "overweight" rating in a research note issued to investors on Friday, Marketbeat.com reports. The brokerage currently has a $70.00 target price on the stock. KeyCorp's price objective suggests a potential upside of 18.66% from the company's previous close.

A number of other brokerages have also recently issued reports on DOCS. Evercore ISI upped their target price on Doximity from $34.00 to $45.00 and gave the stock an "in-line" rating in a report on Tuesday, October 8th. Canaccord Genuity Group raised their price objective on shares of Doximity from $37.00 to $40.00 and gave the company a "buy" rating in a report on Tuesday, August 20th. JPMorgan Chase & Co. boosted their target price on shares of Doximity from $27.00 to $30.00 and gave the stock a "neutral" rating in a report on Monday, August 19th. Bank of America upped their price target on shares of Doximity from $32.00 to $45.00 and gave the company a "neutral" rating in a research report on Monday, October 7th. Finally, Barclays upgraded shares of Doximity from an "equal weight" rating to an "overweight" rating and lifted their price target for the stock from $35.00 to $52.00 in a report on Tuesday, October 15th. One analyst has rated the stock with a sell rating, eight have given a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, Doximity has an average rating of "Hold" and an average price target of $42.43.

Read Our Latest Stock Analysis on DOCS

Doximity Trading Up 35.9 %

DOCS stock traded up $15.57 during mid-day trading on Friday, hitting $58.99. The stock had a trading volume of 6,482,001 shares, compared to its average volume of 1,684,259. The firm has a fifty day simple moving average of $41.12 and a 200 day simple moving average of $32.82. Doximity has a 52 week low of $20.28 and a 52 week high of $60.90. The firm has a market capitalization of $10.95 billion, a P/E ratio of 73.20, a P/E/G ratio of 5.03 and a beta of 1.30.

Doximity (NASDAQ:DOCS - Get Free Report) last posted its earnings results on Thursday, August 8th. The company reported $0.22 EPS for the quarter, topping analysts' consensus estimates of $0.16 by $0.06. The firm had revenue of $126.68 million during the quarter, compared to analysts' expectations of $119.88 million. Doximity had a net margin of 32.53% and a return on equity of 19.26%. As a group, equities analysts expect that Doximity will post 0.8 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Doximity

Several large investors have recently added to or reduced their stakes in DOCS. GAMMA Investing LLC lifted its stake in shares of Doximity by 40.1% during the 3rd quarter. GAMMA Investing LLC now owns 1,439 shares of the company's stock valued at $63,000 after buying an additional 412 shares in the last quarter. Van ECK Associates Corp lifted its stake in Doximity by 19.7% in the 2nd quarter. Van ECK Associates Corp now owns 2,590 shares of the company's stock worth $72,000 after purchasing an additional 427 shares in the last quarter. Cornercap Investment Counsel Inc. boosted its holdings in Doximity by 3.2% in the 2nd quarter. Cornercap Investment Counsel Inc. now owns 17,143 shares of the company's stock valued at $479,000 after purchasing an additional 537 shares during the period. Farther Finance Advisors LLC grew its position in shares of Doximity by 324.2% during the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company's stock valued at $34,000 after purchasing an additional 603 shares in the last quarter. Finally, KBC Group NV increased its holdings in shares of Doximity by 22.9% in the third quarter. KBC Group NV now owns 3,296 shares of the company's stock worth $144,000 after purchasing an additional 614 shares during the period. Hedge funds and other institutional investors own 87.19% of the company's stock.

Doximity Company Profile

(Get Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Featured Stories

Analyst Recommendations for Doximity (NASDAQ:DOCS)

→ Urgent: This election is rigged (From Porter & Company) (Ad)

Should you invest $1,000 in Doximity right now?

Before you consider Doximity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.

While Doximity currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines